Optically active pyridyl-4h-1,2,4-oxdadiazine derivative and its use in the treatment of vascular diseases
US6384029B1 · kind B1 · utility
13Cited by
0References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 15, 2001 |
| Grant date | May 7, 2002 |
| Priority date | — |
| Expiry date | May 15, 2021 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P9/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to (−)-5,6-dihydro-5-(1-piperidinyl)-methyl-3-(3-pyridyl)-4H-1,2,4-oxadiazine to the therapeutical use thereof and to phamaceutical compositions containing the compounds as active ingredient.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.